|
Volumn 143, Issue 4, 2012, Pages
|
HeartWare continuous-flow ventricular assist device thrombosis: The Bad Oeynhausen experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
HEMOGLOBIN;
HEPARIN;
LACTATE DEHYDROGENASE;
PHENPROCOUMON;
TENECTEPLASE;
ADULT;
ARTICLE;
BIVENTRICULAR ASSIST DEVICE;
BLEEDING;
BLOOD FLOW;
CARDIOPULMONARY BYPASS;
DRUG DOSE REDUCTION;
DRUG DOSE TITRATION;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FEMALE;
FIBRINOLYTIC THERAPY;
HEART VENTRICLE THROMBOSIS;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LEFT VENTRICULAR ASSIST DEVICE;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RECURRENCE RISK;
REOPERATION;
SINGLE DRUG DOSE;
STERNOTOMY;
ADULT;
ANTICOAGULANTS;
DEVICE REMOVAL;
EQUIPMENT FAILURE;
FEMALE;
GERMANY;
HEART-ASSIST DEVICES;
HUMANS;
MALE;
MEDICATION ADHERENCE;
MIDDLE AGED;
PROSTHESIS DESIGN;
THROMBOLYTIC THERAPY;
THROMBOSIS;
TREATMENT OUTCOME;
|
EID: 84858341579
PISSN: 00225223
EISSN: 1097685X
Source Type: Journal
DOI: 10.1016/j.jtcvs.2011.12.035 Document Type: Article |
Times cited : (44)
|
References (5)
|